Ftse Mib
38.018,11
-0,54%
DAX
22.575,59
-0,14%
S&P 500
5.610,32
-0,08%
NASDAQ
17.554,08
0,49%
Bitcoin
81.025,52
3,26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Alto Neuroscience Inc (ANRO) Alto Neuroscience Inc (ANRO) Notizie

Alto Neuroscience Inc

ANRO
3,21
-0,12 (-3,60%)
Ultimo aggiornamento: 14:46:55
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/2/202514:03BWAlto Neuroscience to Participate in Upcoming Investor..
19/2/202514:03BWAlto Neuroscience Announces U.S. Patent Granted Covering..
12/2/202514:16EDGAR2Form 8-K - Current report
12/2/202514:03BWAlto Neuroscience Announces Favorable Outcome from Interim..
12/2/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
07/2/202522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202522:39EDGAR2Form 8-K - Current report
03/2/202522:07EDGAR2Form S-3 - Registration statement under Securities Act of..
16/1/202513:00EDGAR2Form 8-K - Current report
06/1/202522:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202414:03BWAlto Neuroscience Announces Data Presented at the 63rd..
14/11/202413:00EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
12/11/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:20EDGAR2Form 8-K - Current report
12/11/202422:10BWAlto Neuroscience Reports Third Quarter 2024 Financial..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/11/202414:00BWAlto Neuroscience to Participate in Upcoming Investor..
22/10/202422:35EDGAR2Form 8-K - Current report
22/10/202422:30BWAlto Neuroscience Reports Topline Results from a Phase 2b..
04/9/202414:05BWAlto Neuroscience Announces Peer-Reviewed Publication in the..
03/9/202414:05BWAlto Neuroscience to Participate in Upcoming Investor..
13/8/202422:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:33EDGAR2Form 8-K - Current report
13/8/202422:05BWAlto Neuroscience Reports Second Quarter 2024 Financial..
29/7/202422:19EDGAR2Form 8-K - Current report
25/7/202414:30BWAlto Neuroscience Receives Funding Award from Wellcome Trust..
16/7/202413:30BWAlto Neuroscience Announces Enrollment Completion in Phase..
11/7/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/6/202414:05BWAlto Neuroscience Initiates Phase 2 Study of ALTO-101, a..
18/6/202414:05BWAmit Etkin, M.D., Ph.D., Founder and CEO of Alto..
29/5/202414:05BWAlto Neuroscience to Present at the Jefferies Global..
21/5/202414:29EDGAR2Form 8-K - Current report
21/5/202414:05BWAlto Neuroscience Appoints Michael Hanley as Chief Operating..
14/5/202422:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:25EDGAR2Form 8-K - Current report
14/5/202422:03BWAlto Neuroscience Reports First Quarter 2024 Financial..
09/5/202414:05BWAlto Neuroscience Announces Data Presentations Highlighting..
23/4/202414:05BWAlto Neuroscience Announces Positive Phase 1 Results for..
03/4/202414:05BWAlto Neuroscience Announces Initiation of Phase 2 Study of..
21/3/202421:05BWAlto Neuroscience Reports Full Year 2023 Financial Results..
11/3/202413:05BWAlto Neuroscience Appoints Maha Radhakrishnan, M.D., to..
Apertura: 3,26 Min: 3,05 Max: 3,29
Chiusura: 3,33

La tua Cronologia

NYSE
ANRO
Alto Neuroscience
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci